berotek has been researched along with Alloxan Diabetes in 2 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozakca, I | 1 |
| Arioglu, E | 1 |
| Guner, S | 1 |
| Altan, VM | 2 |
| Ozcelikay, AT | 2 |
| Dinçer, UD | 1 |
| Onay, A | 1 |
| Ari, N | 1 |
2 other studies available for berotek and Alloxan Diabetes
| Article | Year |
|---|---|
Role of beta-3-adrenoceptor in catecholamine-induced relaxations in gastric fundus from control and diabetic rats.
Topics: Animals; Catecholamines; Diabetes Mellitus, Experimental; Ethanolamines; Fenoterol; Gastric Fundus; | 2007 |
The effects of diabetes on beta-adrenoceptor mediated responsiveness of human and rat atria.
Topics: Adrenergic beta-Agonists; Aged; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Female; | 1998 |